Business
Amgen Announces Webcast Of 2020 Second Quarter Financial Results
THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday,
About this update from Amgen Inc.
[{"type":"text","content":"THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.\nLive audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.\nThe webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.\nAbout AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.\nAmgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. \nFor more information, visit www.amgen.com and follow us on www.twitter.com/amgen. \nCONTACT: Amgen, Thousand Oaks Megan Fox, 805-447-1423 (media) Trish Rowland, 805-447-5631 (media) Arvind Sood, 805-447-1060 (investors) \n\n \n\n\n\n View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-second-quarter-financial-results-301099104.html\nSOURCE Amgen","length":4812,"tagName":"div"}]